|Bid||43.05 x 800|
|Ask||49.00 x 900|
|Day's range||43.04 - 43.72|
|52-week range||27.05 - 48.61|
|Beta (5Y monthly)||1.61|
|PE ratio (TTM)||11.67|
|Earnings date||29 Jul 2021 - 02 Aug 2021|
|Forward dividend & yield||1.88 (4.18%)|
|Ex-dividend date||07 May 2021|
|1y target est||52.33|
(Bloomberg) -- EQT AB is weighing an initial public offering of Azelis, a distributor of specialty chemicals and food ingredients, according to people familiar with the matter.The private equity firm is being advised by Lazard Ltd. on the listing plans, the people said, asking not to be identified discussing confidential information. Azelis could be valued at about 5 billion euros ($6 billion) in any IPO, the people said. Goldman Sachs Group Inc. and JPMorgan Chase & Co. are also working on the
Lazard's (LAZ) May AUM is up sequentially to $278.6 billion on market appreciation and favorable foreign-exchange impact.
Lazard Ltd (NYSE: LAZ) reported today that its preliminary assets under management ("AUM") as of May 31, 2021 totaled approximately $278.6 billion. The month’s AUM included market appreciation of $3.4 billion, foreign exchange appreciation of $1.9 billion and net outflows of $1.1 billion.